Eukaryotic antimicrobial peptides: Promises and premises in food safety

Journal of Food Science

Volumn 71, Issue 9, 2006, Pages

  Rydlo, Tali ^a   Miltz, Joseph ^a   Mor, Amram ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antimicrobial packaging; Antimicrobial resistance; Drug design; Food pathogens

Indexed keywords

ANIMALIA; BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; EUKARYOTA;

EID: 33845437977     PISSN: 00221147     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1750-3841.2006.00175.x     Document Type: Review

References (194)

1. Abler LA, Klapes NA, Sheldon BW, Klaenhammer TR. 1995. Inactivation of food-borne pathogens with magainin peptides. J Food Prot 58:381-8.
2. Amiche M, Ducancel F, Mor A, Boulain JC, Menez A, Nicolas P. 1994. Precursors of vertebrate peptide antibiotics dermaseptin B and adenoregulin have extensive sequence identities with precursors of opioid peptides dermorphin, dermenkephalin, and deltorphins. J Biol Chem 269:17847-52.
3. Amiche M, Seon AA, Pierre T, Nicolasm P. 1999. The dermaseptin precursors: a protein family with a common preproregion and a variable C-terminal antimicrobial domain. FEBS Lett 456:352-6.
4. Andrea D, Rivas L. 1998. Animal antimicrobial peptides: an overview. Biopolymers 47:415-33.
5. Annamalai T, Venkitanarayanan KS, Hoagland TA, Khan MI. 2001. Inactivation of Escherichia coli O157:H7 and Listeria monocytogenes by PR-26, a synthetic antibacterial peptide. J Food Prot 64:1929-34.
6. Anonymous. 1995. Escherichia coli O157:H7 outbreak linked to commercially distributed dry-cured salami - Washington and California. Morb Mortal Wkly Rep 44:157-60.
7. Appendini P, Hotchkiss JH. 1999. Antimicrobial activity of a 14-residue peptide against Escherichia coli O157:H7. J Appl Microbiol 87(5):750-6.
8. Appendini P, Hotchkiss JH. 2000. Antimicrobial activity of a 14-residue synthetic peptide against foodborne microorganisms. J Food Prot 63:889-93.
9. Appendini P, Hotchkiss JH. 2002. Review of antimicrobial food packaging. Inno Food Sci Emerging Technol 3:113-26.
10. Auvynet C, Seddiki N, Dunia I, Nicolas P, Amiche M, Lacombe C. 2006. Post-translational amino acid racemization in the frog skin peptide deltorphin I in the secretion granules of cutaneous serous glands. Eur J Cell Biol 85(1):25-34.
11. Aymerich T, Holo H, Havarstein LS, Hugas M, Garriga M, Nes IF. 1996. Biochemical and genetic characterization of enterocin A from Enterococcus faecium, a new antilisterial bacteriocin in the pediocin family of bacteriocins. Appl Environ Microbiol 62:1676-82.
12. Bals R. 2000. Epithelial antimicrobial peptides in host defense against infection. Respir Res 3:141-50.
13. Bechinger B. 1996. Towards membrane protein design: pH-sensitive topology of histidine-containing polypeptides. J Mol Biol 263:768-75.
14. Belaid A, Aounim M, Khelifa R, Trabelsi A, Jemmali M, Hani K. 2002. In vitro antiviral activity of dermaseptins against herpes simplex virus type I. J Med Virol 66:229-34.
15. Besser RE, Lett SM, Weber JT, Doyle MP, Barrett TI, Wells JG, Grin PM. 1993. An outbreak of diarrhea and hemolytic uremic syndrome from Escherichia coli O157:H7 in fresh-pressed apple cider. JAMA 269:2217-20.
16. Bevins CL, Zasloff M. 1990. Peptides from frog skin. Annu Rev Biochem 59:395-414.
17. Blondelle SE, Houghten RA. 1992. Design of model amphipathic peptides having potent antimicrobial activities. Biochemistry 31(50):12688-94.
18. Boman HG. 1995. Peptide antibiotics and their role in innate immunity. Annu Rev Immunol 13:61-92.
19. Boman HG, Faye I, Gudmundsson GH, Lee JY, Lidholm DA. 1991. Cell-free immunity in Cecropia. A model system for antibacterial proteins. Eur J Biochem 201:23-31.
20. Boman HG, Agerberth B, Boman A. 1993. Mechanisms of action on Escherichia coli of cecropin P1 and PR-39, two antibacterial peptides from pig intestine. Infect Immun 61:2978-84.
21. Boziaris IS, Humpheso L, Adams MR. 1998. Effect of nisin on heat injury and inactivation of Salmonella enteritidis PT4. Int J Food Microbiol 43:7-13.
22. Branen JK, Davidson PM. 2004. Enhancement of nisin, lysozyme, and monolaurin antimicrobial activities by ethylenediaminetetraacetic acid and lactoferrin. Int J Food Microbiol 90:63-74.
23. Brogden KA. March 2005. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Revi Microbiol 3:238-50. Available from: www.nature.com/reviews/micro.
24. Brown JL, Ross T, McMeekin TA, Nichols PD. 1997. Acid habituation of Escherichia coli and potential role of cyclopropane fatty acids in low pH tolerance. Int J Food Microbiol 37:163-73.
25. Buchanan RL, Doyle MP. 1997. Foodborne disease significance of Escherichia coli O157:H7 and other enterohemorrhagic E. coli. Food Technol 51(10):69-76.
26. Bulet P, Dimarcq JL, Hetru C, Lagueux M, Charlet M, Hegy G, Dorsselaer AV, Hoffmann JA. 1993. A novel inducible antibacterial peptide of Drosophila carries an O-glycosylated substitution. J Biol Chem 268:14893-7.
27. Burrowes OJ, Hadjicharalambous C, Diamond G, Lee TC. 2004. Evaluation of antimicrobial spectrum and cytotoxic activity of pleurocidin for food applications. J Food Sci 69(3):66-71.
28. Cabiaux V, Agerberth B, Johansson J, Homble F, Goormaghtigh E, Ruysschaert M. 1994. Secondary structure and membrane interaction of PR-39, a Pro+Arg-rich antibacterial peptide. Eur J Biochem 224:1019-27.
29. Charpentier S, Amiche M, Mester J, Vouille V, Le Caer JP, Nicolas P, and Delfour D. 1998. Structure, synthesis and molecular cloning of dermaseptin B, family of skin peptide antibiotics. J Biol Chem 273:14690-7.
30. Chen H, Hoover DG. 2003. Bacteriocins and their food applications. Comp Rev Food Sci Safety 2:82-100.
31. Chen H, Xu Z, Xu N, Cen P. 2005. Efficient production of a soluble fusion protein containing human beta-defensin-2 in E. coli cell-free system. J Biotechnol 115(3):307-15.
32. Chen J, Falla TJ, Liu H, Hurst MA, Fujii CA, Mosca DA, Embree JR, Loury DJ, Radel PA, Cheng Chang C, Gu L, Fiddes JC. 2000. Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues. Biopolymers 55(1):88-98.
33. Chen T, Tang L, Shaw C. 2003. Identification of three novel Phyllomedusa sauvagei dermaseptins (sVI-sVIII) by cloning from a skin secretion-derived cDNA library. Regul Pept 116(1-3):139-46.
34. Cheville AM, Arnold KW, Buchrieser C, Cheng CM, Kaspar CW. 1996. RpoS regulation of acid, heat, and salt tolerance in Escherichia coli O157:H7. Appl Environ Microbiol 62:1822-4.
35. Cintas LM, Casaus P, Havarstein LS, Hernandez PE, Nes IF. 1997. Biochemical and genetic characterization of enterocin P, a novel secdependent bacteriocin from Enterococcus faecium P13 with a broad antimicrobial spectrum. Appl Environ Microbiol 63:4321-30.
36. Cleveland J, Montville TJ, Nes IF, Chikindas ML. 2001. Bacteriocins: safe, natural antimicrobials for food preservation. Int J Food Microbiol 71:1-20.
37. Cole A, Weis P, Diamond G. 1997. Isolation and characterization of pleurocidin, an antimicrobial peptide in the skin secretions of winter flounder. J Biol Chem 272(18):1208-13.
38. Cole A, Darouiche R, Legarda D, Connell N, Diamond G. 2000. Characterization of a fish antimicrobial peptide: gene expression, subcellular localization and spectrum of activity. Antimicrob Agents Chemother 44:2039-45.
39. Coote PJ, Holyoak CD, Bracey D, Ferdinando DP, Pearce JA. 1998. Inhibitory action of a truncated derivative of the amphibian skin peptide dermaseptin s3 on Saccharomyces cerevisiae. Antimicrob Agents Chemother 42:2160-70.
40. Csordas A, Michl H. 1970. Isolation and structural resolution of a haemolytically active polypeptide from the immune secretion of a European toad. Monatsh Chem 101:182-9.
41. Cutter CN, Siragusa G. 1995. Population reductions of Gram negative pathogens following treatments with nisin and chelators under various conditions. J Food Prot 58:977-83.
42. Dagan A, Efron L, Gaidukov L, Mor A, Ginsburg H. 2002. In vitro antiplasmodium effects of dermaseptin S4 derivatives. Antimicrob Agents Chemother 46:1059-66.
43. Darveau RP, Cunningham MD, Seachord CL, Cassiano-Clough L, Cosand WL, Blake J, Watkins CS. 1991. Beta-lactam antibiotics potentiate magainin 2 antimicrobial activity in vitro and in vivo. Antimicrob Agents Chemother 35:1153-9.
44. DeLucca AJ, Bland JM, Jack TJ, Grimm C, Walsh YJ. 1998. Fungicidal and binding properties of the natural peptides cecropin B and dermaseptin. Med Mycol 36:291-8.
45. Dodd CE, Aldsworth TG. 2002. The importance of RpoS in the survival of bacteria through food processing. Int J Food Microbiol 74:189-94.
46. Donini M, Lico C, Baschieri S, Conti S, Magliani W, Polonelli L, Benvenuto E. 2005. Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system. Appl Environ Microbiol 71(10):6360-7.
47. Doyle MP. 1991. Escherichia coli O157:H7 and its significance in foods. Int J Food Microbiol 12:289-301.
48. Efron L, Dagan A, Gaidukov L, Ginsburg H, Mor A. 2002. Direct interaction of dermaseptin S4 aminoheptanoyl derivative with intraerythrocytic malaria parasite leading to increased specific antiparasitic activity in culture. J Biol Chem 277:24067-72.
49. Fang FC, Chen CY, Guiney DG, Xu Y. 1996. Identification of sigma S-regulated genes in Salmonella typhimurium: complementary regulatory interactions between sigma S and cyclic AMP receptor protein. J Bacteriol 178:5112-20.
50. Fazio MA, Oliveira VX Jr, Bulet P, Miranda MT, Dalfre S, Miranda A. 2005. Structure-activity relationship studies of gomesin: importance of the disulfide bridges for conformation, bioactivities and serum stability. Biopolymer 84(2):205-18.
51. FDA (U.S. Food and Drug/Administration)/Federal Register. 1988. 21 CFR Part 184. Fed Reg 53:11247-51.
52. Feder R, Dagan A, Mor A. 2000. Structure-activity relationship study of antimicrobial dermaseptin S4 showing the consequences of peptide oligomerization on selective cytotoxicity. J Biol Chem 275:4230-8.
53. Feder R, Nehushtani R, Mor A. 2001. Affinity driven molecular transfer from erythrocyte membrane to target cells. Peptides 22:1683-90.
54. Foster JW, Spector MP. 1995. How Salmonella survive against the odds. Annu Rev Microbiol 49:145-74.
55. Friedrich C, Scott MG, Karunaratne N, Yan H, Hancock REW. 1999. Salt-resistant alpha-helical cationic antimicrobial peptides. Antimicrob Agents Chemother 43:1542-8.
56. Friedrich CL, Moyles D, Beveridge TJ, Hancock REW. 2000. Antibacterial action of structurally diverse cationic peptides on Gram-positive bacteria. Antimicrob Agents Chemother 44:2086-92.
57. Futaki S, Suzuki T, Ohashi T, Yagami T, Tanaka S, Ueda K, Sugiura Y. 2001. Arginine-rich peptides. An abundant source of membrane permeable peptides having potential as carriers for intracellular protein delivery. J Biol Chem 276:5836-40.
58. Gaidukov L, Fish A, Mor A. 2003. Analysis of membrane-binding properties of dermaseptin analogues: relationships between binding and cytotoxicity. Biochem 41:12866-74.
59. Ganzle MG, Hertel C, Hammes WP. 1999. Resistance of Escherichia coli and Salmonella against nisin and curvacin A. Int J Food Microbiol 48:37-50.
60. Ge Y, MacDonald DL, Halroyd KJ, Thornsberry C, Wexler H, Zasloff M. 1999a. In vitro antibacterial properties of pexiganan. Antimicrob Agents Chemother 43:782-8.
61. Ge Y, MacDonald DL, Henry MM, Hait HI, Nelson KA, Lipsky BA, Zasloff M, Holroyd KJ. 1999b. In vitro susceptibility to pexiganan of bacteria isolated from infected diabetic foot ulcers. Diagn Micrbiol Infect Dis 35:45-53.
62. Ghosh JK, Shaool D, Guillaud P, Ciceron L, Mazier D, Kustanovich I, Shay Y, Mor A. 1997. Selective cytotoxicity of dermaseptin S3 towards intraerythrocytic Plasmodium falciparum and the underlying molecular basis. J Biol Chem 267:6502-9.
63. Gold HS, Moellering RC. 1996. Antimicrobial-drug resistance. N Engl J Med 335:1445-53.
64. Griffin PM, Tauxe RV. 1991. The epidemiology of infections caused by Escherichia coli O157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 13:60-98.
65. Gudmundsson GH, Agerberth B. 1999. Neutrophil antibacterial peptides, multifunctional effector molecules in the mammalian immune system. J Immunol Methods 232:45-54.
66. Habermann E. 1972. Bee and wasp venoms. Science 177:314-22.
67. Hancock REW. 1997. Peptide antibiotics. Lancet 349:418-22.
68. Hancock REW. 2001. Cationic peptides: effectors in innate immunity and novel antimicrobials. Lancet Infectious Disease. 1:156-64.
69. Hancock REW, Lehrer RI. 1998. Cationic peptides: a new source of antibiotics. Trends Biotechnol 16:82-8.
70. Hancock REW, Chapple DS. 1999. Peptide antibiotics. Antimicrob Agents Chemother 43:1317.
71. Hancock REW, Diamond G. 2000. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 8:402-10.
72. Hancock REW, Patrzykat A. 2002. Clinical development of cationic antimicrobial peptides: from natural to novel antibiotics. Curr Drug Targets Infect Disord 2:79-83.
73. Hansen LT, Gill TA. 2000. Solubility and antimicrobial efficacy of protamine on Listeria monocytogenes and Escherichia coli as influenced by pH. J Appl Microbiol 88:1049-55.
74. Hansen LT, Austin JW, Gill TA. 2001. Antibacterial effect of protamine in combination with EDTA and refrigeration. Int J Food Microbiol 66:149-61.
75. Hariton-Gazal EH, Feder R, Mor A, Graessmann A, Werner RB, Jans D, Gilon C, Loyter A. 2002. Targeting of nonkaryophilic cell-permeable peptides into the nuclei of intact cells by covalently attached nuclear localization signals. Biochemistry 41(29):9208-14.
76. Hastings JW, Sailer M, Johnson K, Roy KL, Vederas JC, Stiles ME. 1991. Characterization of leucocin A-UAL 187 and cloning of the bacteriocin gene from Leuconostoc gelidum. J Bacteriol 173:7491-500.
77. Haynie SL, Crum GA, Doele BA. 1995. Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin. Antimicrob Agents Chemother 39:301-7.
78. Henriques M, Quintas C, Loureiro-Dias MC. 1997. Extrusion of benzoic acid in Saccharomyces cerevisiae by energy-dependent mechanism. Microbiology 143:1877-83.
79. Hernandez C, Mor A, Dagger F, Nicolas P, Hernandez A, Benedetti EL, Dunia I. 1992. Functional and structural damage in Leishmania mexicana exposed to the cationic peptide dermaseptin. Eur J Cell Biol 59:414-24.
80. Hirsch A, Mattick ATR. 1949. Some recent applications of nisin. Lancet (2):190-3.
81. Holyoak CD, Stratford M, McMullin Z, Cole MB, Crim FK, Brown AJP, Coote P. 1996. Activity of the plasma membrane H(+)-ATPase and optimal glycolytic flux are required for rapid adaptation and growth of Saccharomyces cerevisiae in the presence of the weak-acid preservative sorbic acid. Appl Environ Microbiol 62:3158-64.
82. Huang HW. 2000. Action of antimicrobial peptides: 2-state model. Biochem 39:8347-52.
83. Hurst A. 1981. Nisin. Adv Appl Microbiol 27:85-123.
84. Islam NMD, Itakura T, Motohiro T. 1984. Antibacterial spectra and minimum inhibition concentration of clupeine and salmine. Bull Jpn Soc Sci Fish 50:1705-8.
85. Islam NMD, Oda H, Motohiro T. 1987. Changes in the cell morphology and the release of soluble constituents from washed cells of Bacillus subtilis by the action of protamine. Nippon Suisan Gakkaishi 53:297-303.
86. Johansen C, Gill T, Gram L. 1995. Antibacterial effect of protamine assayed by impedimetry. J App Bacteriolog 78:297-303.
87. Johansen C, Verheul A, Gram L, Gill T, Abee T. 1997. Protamine-induced permeabilization of cell envelopes of Gram-positive and Gram-negative bacteria. Apple Enviro Microbiol 63:1155-9.
88. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. 1998. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J Biol Chem 273:3718-24.
89. Jouenne T, Mor A, Bonato H, Junter GA. 1998. Antibacterial activity of synthetic dermaseptins against growing and non-growing Escherichia coli cultures. J Antimicrob Chemother 42:87-90.
90. Jung D, Bodyfelt FW, Daeschel MA. 1992. Influence of fat and emulsifiers on the efficacy of nisin in inhibiting Listeria monocytogenes in fluid milk. J Dairy Sci 75:387-93.
91. Kamysz W, Okroj M, Lukasiak J. 2003. Novel properties of antimicrobial peptides. Acta Biochimica Polonica 50(2):461-9.
92. Kathariou S. 2002. Listeria monocytogenes virulence and pathogenicity, a food safety perspective. J Food Prot 65:1811-29.
93. Kaur K, Andrew LC, Wishart DS, Vederas JC. 2004. Dynamic relationships among type IIa bacteriocins: temperature effects on antimicrobial activity and on structure of the C-terminal amphipathic alpha helix as a receptor-binding region. Biochem 43:9009-20.
94. Kilara A, Panyam D. 2003. Peptides from milk proteins and their properties. Crit Rev Food Sci Nutr 43(6):607-33.
95. Kim HS, Yoon H, Minn I, Park CB, Lee WT, Zasloff M, Kim SH. 2000. Pepsin-mediated processing of the cytoplasmic histone H2A to strong antimicrobial peptide buforin I. J Immunol 165:3268-74.
96. Kojima S, Kuriki Y, Sato Y, Arisaka F, Kumagai I, Takahashi S, Miura K. 1996. Synthesis of alpha-helix-forming peptides by gene engineering methods and their characterization by circular dichroism spectra measurements. Biochim Biophys Acta 1294:129-37.
97. Krugliak M, Feder R, Zolotarev VY, Gaidukov L, Dagan A, Ginsburg H, Mor A. 2000. Antimalarial activities of dermaseptin S4 derivatives. Antimicrob Agents Chemother 44:2442-51.
98. Kustanovich I, Shalev DE, Mikhlin M, Gaidukov L, Mor A. 2002. Structural requirements for potent versus selective cytotoxicity for antimicrobial dermaseptin S4 derivatives. J Biol Chem 277(19):16941-51.
99. Lee IH, Cho Y, Lehrer R. 1997. Effects of pH and salinity on the antimicrobial properties of clavanins. Infec Immun 65:2898-903.
100. Lehrer RI, Ganz T. 1999. Antimicrobial peptides in mammalian and insect host defence. Curr Opin Immunol 11:23-7.
101. Lequin O, Bruston F, Convert O, Chassaing G, Nicolas P. 2003. Helical structure of dermaseptin B2 in a membrane-mimetic environment. Biochemistry 42:10311-23.
102. Lin JS, Smith MP, Chapin KC, Baik HS, Bennett GN, Foster JW. 1996. Mechanisms of acid resistance in enterohemorrhagic Escherichia coli. Appl Environ Microbiol 62:3094-100.
103. Lorin C, Saidi H, Belaid A, Zairi A, Baleux F, Hocini H, Belec L, Hani K, Tangy F. 2005. The antimicrobial peptide dermaseptin S4 inhibits HIV-1 infectivity in vitro. Virology 334:264-75.
104. Maisnier-Patin S, Forni E, Richard J. 1996. Purification, partial characterisation and mode of action of enterococcin EFS2, an antilisterial bacteriocin produced by a strain of Enterococcus faecalis isolated from a cheese. Int J Food Microbiol 30:255-70.
105. Marion D, Zasloff M, Bax M. 1988. A two-dimensional NMR study of the antimicrobial peptide magainin 2. FEBS Lett 227(1):21-6
106. Matsuzaki K. 1998. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim Biophys Acta 1376:391-400.
107. Matsuzaki K. 1999. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim Biophys Acta 1426:1-10.
108. Matsuzaki K, Mitani Y, Akada KY, Murase O, Yoneyama S, Zasloff M, Miyajima K. 1998. Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa. Biochemistry 37:15144-53.
109. Mayrhofer M, Paulsen P, Smulders FJM, Hilbert F. 2004. Antimicrobial resistance profile of five major food-borne pathogens isolated from beef, pork and poultry. Int J Food Microbiol 97(1):23-9.
110. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JF, Shapiro C, Griffin PM, Tauxe RV. 1999. Food-related illness and death in the United States. Emerging Infect Dis 5(5):607-25.
111. Meister M, Lemaitre B, Hoffmann JA. 1997. Antimicrobial peptide defense in Drosophila. Bioessays 19:1019-26.
112. Melendez-Alafort L, Rodriguez-Cortes J, Ferro-Flores G, Arteaga De Murphy C, Herrera-Rodriguez R, Mitsoura E, Martinez-Duncker C. 2004. Biokinetics of (99m)Tc-UBI 29-41 in humans. Nucl Med Biol 31(3):373-9.
113. Mendoza F, Maqueda M, Galvez A, Martinez-Bueno M, Valdivia E. 1999. Antilisterial activity of peptide AS-48 and study of changes induced in the cell envelope properties of an AS-48-adapted strain of Listeria monocytogenes. Appl Environ Microbiol 65:618-25.
114. Miltz J, Passy N, Mannheim CH. 1995. Trends and applications of active packaging systems. In: Ackerman P, Jagerstad M, Ohlsson M, editors. Food and packaging materials - chemical interaction. The Royal Soc. of Chemistry Publ. No 162, p 201-10.
115. Miltz J, Bigger SW, Sonneveld C, Suppakul P. 2004. Antimicrobial Packaging Material. Australian Patent Application No. 2004903510.
116. Miltz J, Rydlo T, Mor A, Polyakov V. 2006. Potency evaluation of a dermaseptin s4 derivative for antimicrobial food packaging applications. Packag Technol Sci. Online May 24. http://www3.interscience.wiley.com/cgi-bin/abstract/ 112636230/ABSTRACT?CRETRY=1&SRETRY=0
117. Miltz J, Rydlo T, Mor A, Polyakov V. 24 May 2006. Potency evaluation of a dermaseptin s4 derivative for antimicrobial food packaging applications. Packag Technol Si-Published Online.
118. Montville TJ, Winkowski K, Ludescher RD. 1995. Models and mechanisms for bacteriocin action and application. Int Dairy J 5:797-814.
119. Moore KS, Bevins C, Brasseur MM, Tomassini N, Turner K, Eck H, Zasloff M. 1991. Antimicrobial peptides in the stomach of Xenopus laevis. J Biol Chem 266:19851-7.
120. Mor A, Nguyen VH, Delfour A, Migliore SD, Nicolas P. 1991. Isolation, amino acid sequence, and synthesis of dermaseptin, a novel antimicrobial peptide of amphibian skin. Biochemistry 3:8824-30.
121. Mor A, Hani K, Nicolas P. 1994a. The vertebrate peptide antibiotics dermaseptins have overlapping structural features but target specific microorganisms. J Biol Chem 269:31635-41.
122. Mor A. 2000. Peptide-based antibiotics: a potential answer to raging antimicrobial resistance. Drug Dev Res 50:440-7.
123. Mor A. 2001. Antimicrobial peptides. The Kirk-Othmer encyclopedia of chemical technology by Wiley InterScience. John Wiley & Sons Inc. Available from: http://www.mrw.interscience.wiley.cam:8095/articles/peptwise.a01/frame. html.
124. Mor A, Nicolas P. 1994a. Isolation and structure of novel defensive peptides from frog skin. Eur J Biochem 219:145-54.
125. Mor A, Nicolas P. 1994b. The NH2-terminal helical domain 1-18 of dermaseptin is responsible for antimicrobial activity. J Biol Chem 269:1934-9.
126. Mor A, Amiche M, Nicolas P. 1994b. Structure, synthesis, and activity of dermaseptin B, a novel vertebrate defensive peptide from frog skin: relationship with adenoregulin. Biochemistry 33:6642-50.
127. Muriana P. 1993. Antimicrobial peptides and their relation to food quality. In: Spanier AM, Okai H, Tamura M, editors. Food flavor and safety. Molecular analysis and design. Washington, D.C.: American Chemical Society. 303-21.
128. Mygind PH, Fischer RL, Schnorr KM, Hansen MT, Sonksen CP, Ludvigsen S, Raventos D, Buskov S, Christensen B, De Maria L, Taboureau O, Yaver D, Elvig-Jorgensen SG, Sorensen MV, Christensen BE, Kjaerulff S, Frimodt-Moller N, Lehrer RI, Zasloff M, Kristensen HH. 2005. Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature 437:975-80.
129. Navon-Venezia S, Feder R, Gaidukov L, Carmeli Y, Mor A. 2002. Antibacterial properties of dermaseptin S4 derivatives with in vivo activity. Antimicrob Agents Chemother 46:689-94.
130. Nicolas P, Mor A. 1995. Peptides as a weapon against microorganisms in the chemical defense system of vertebrates. Annu Rev Microbiol 49:277-304.
131. Nicolas P, Vanhoye D, Amiche M. 2003. Molecular strategies in biological evolution of antimicrobial peptides. Peptides 24:1669-80.
132. Nielsen JW, Dickson JS, Grouse JD. 1990. Use of a bacteriocin produced by Pediococcus acidilactici to inhibit Listeria monocytogenes associated with fresh meat. Appl Environ Microbiol 56:2142-5.
133. Oh JE, Hong SY, Lee KH. 1999. Structure-activity relationship study: short antimicrobial peptides. J Pept Res 53(1):41-6.
134. Osusky M, Zhou G, Osuska L, Hancock RE, Kay WW, Misra S. 2000. Transgenic plants expressing cationic peptide chimeras exhibit broad-spectrum resistance to phytopathogens. Nat Biotechnol 18:1162-6.
135. Papagianni M. 2003. Ribosomally synthesized peptides with antimicrobial properties: biosynthesis, structure, function, and applications. Biotechnol Adv 21:465-99.
136. Papo N, Braunstein A, Esbhar Z, Shai Y. 2004. Suppression of human prostate tumor growth in mice by a cytolytic D-, L-amino acid peptide: membrane lysis, increased necrosis, and inhibition of prostate-specific antigen secretion. Cancer Res 64:5779-86.
137. Park IY, Cho JH, Kim KS, Kim YB, Kim MS, Kim SC. 2004. Helix stability confers salt resistance upon helical antimicrobial peptides. J Biol Chem 279:13896-901.
138. Park YK, Bearson B, Bang SH, Bang IS, Foster J. 1996. Internal pH crisis, lysine decarboxylase and the acid tolerance response of Salmonella typhimurium. Mol Microbiol 20:605-11.
139. Perez-Paya E, Houghten RA, Blondelle SE. 1994. Determination of the secondary structure of selected melittin analogues with different haemolytic activities. Biochem J 299:587-91.
140. Pouny Y, Rapaport D, Mor A, Nicolas P, Shai Y. 1992. Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes. Biochem 31:12416-23.
141. Projan SJ, Blackburn P. 1993. The bacteriocin nisin activated by chelating agents is bactericidal for Helicobacter pylori in vitro. Gastroenterology 104:173.
142. Radzishevsky IS, Rotem S, Zaknoon F, Gaidukov L, Dagan D, Mor A. 2005. Effects of acyl versus aminoacyl conjugation on the properties of antimicrobial peptides. Antimicrob Agents Chemother 49(6):2412-20.
143. Rayman K, Malik N, Hurst N. 1983. Failure of nisin to inhibit outgrowth of Clostridium botulinum in a model cured meat system. Appl Environ Microbiol 46:1450-2.
144. Richard H, Foster JW. 2004. Escherichia coli glutamate- and arginine-dependent acid resistance systems increase internal pH and reverse transmemhrane potential. J Bacteriol 186:6032-41.
145. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR, Herbert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen ML. 1983. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 308:681-5.
146. Robinson JA, Shankaramma SC, Jetter P, Kienzl U, Schwendener RA, Vrijbloed JW, Obrecht D. 2005. Properties and structure-activity studies of cyclic beta-hairpin peptidomimetics based on the cationic antimicrobial peptide protegrin. J Bioorg Med Chem 13(6):2055-64.
147. Rogers LA. 1928. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J Bacteriol 16:321-5.
148. Rotem S, Radzishevsky I, Inouye RT, Samore M, Mor A. 2006. Identification of antimicrobial peptide regions derived from genomic sequences of phage lysins. Peptides 27(1):18-26.
149. Rydlo T, Rotem S, Mor A. 2006. Antibacterial properties of dermaseptin s4 derivatives under extreme incubation conditions. Antimicrob Agents Chemother 50(2):490-7.
150. Samson RA, Hoekstra E, Frisvad JC, Filtenborg O. 1995. Introduction to food-borne fungi. The Netherlands: CBS, Baarn, p 299.
151. Scott MG, Hancock REW. 2000. Cationic antimicrobial peptides and their multifunctional role in the immune system. Crit Rev Immunol 20:407-31.
152. Scott MG, Yan H, Hancock REW. 1999. Biological properties of structurally related alpha-helical cationic antimicrobial peptides. Infect Immun 67:2005-9.
153. Shalev DE, Mor A, Kustanovich I. 2002. Structural consequences of carboxyamidation of dermaseptin S3. Biochemistry 41:7312-7.
154. Shalev DE, Rotem S, Fish A, Mor A. 2005. Consequences of N-acylation on structure and binding properties of dermaseptin derivative K4S4 (1-13). J Biol Chem 281(14):9432-8.
155. Shi J, Ross CR, Chengappa MM, Style MJ, McVey DS, Blecha F. 1996. Antibacterial activity of a synthetic peptide (PR-26) derived from PR-39, a prolinearginine-rich neutrophil antimicrobial peptide. Antimicrob Agents Chemother 40:115-21.
156. Shinnar AE, Uzzell T, Rao MN, Spooner E, Lane WS, Zasloff MA. 1996. In: Kaumaya PTP, Hodges RS, editors. Peptides chemistry structure and biology, proceedings of the 12th American peptide symposium. London: Mayflower Scientific. 189-91.
157. Simmaco M, Mignogna G, Barra D. 1998. Antimicrobial peptides from amphibian skin: what do they tell us? Biopolymers 47:435-50.
158. Small P, Blankenhorn D, Welty D, Zinser E, Slonczewski, McGarrity JT, Armstrong JB. 1994. Acid and base resistance in Escherichia coli and Shigella flexneri: role of rpoS and growth pH. J Bacteriol 176:1729-37.
159. Soballe PW, Maloy WL, Myrga ML, Jacob LS, Herlyn M. 1995. Experimental local therapy of human melanoma with lytic magainin peptides. Int J Cancer 60:280-4.
160. Steele BT, Murphy N, Rance CP. 1982. An outbreak of hemolytic uremic syndrome associated with ingestion of fresh apple juice. J Pediatr 101:963-5.
161. Stumpe S, Bakker EP. 1997. Requirement of a large K+-uptake capacity and of extracytoplasmic protease activity for protamine resistance of Escherichia coli. Arch Microbiol 167:126-36.
162. Suppakul P, Miltz J, Sonneveld K, Bigger SW. 2003a. Active packaging technologies with an emphasis on antimicrobial packaging and its applications. J Food Sci 68(2):408-20.
163. Suppakul P, Miltz J, Sonneveld K, Bigger SW. 2003b. Antimicrobial properties of basil and its possible application in food packaging. J Agric Food Chem 5:3197-207.
164. Suppakul P, Miltz J, Sonneveld K, Bigger SW. 2006. Characterization of antimicrobial films containing basil extracts. Packag Technol Sci 19(5):259-68.
165. Tailor RH, Acland DP, Attenborough S, Cammue BP, Evans IJ, Osborn RW, Ray JA, Rees SB, Broekaert WF. 1997. A novel family of small cysteine-rich antimicrobial peptides from seed of Impatiens balsamina is derived from a single precursor protein. J Biol Chem 272:24480-7.
166. Tang YQ, Yuan J, Osapay G, Osapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME. 1999. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-defensins. Science 286:498-502.
167. Tauxe RV. 2002. Emerging foodborne pathogens. Int J Food Microbiol 78(1-2):31-41.
168. Thouzeau C, Le Maho Y, Froget G, Sabatier L, Le Bohec C, Hoffmann JA, Bulet P. 2003. Spheniscins, avian beta-defensins in preserved stomach contents of the king penguin. Aptenodytes patagonicus. J Biol Chem 278:51053-8.
169. Tichaczek PS, Vogel RF, Hammes WP. 1994. Cloning and sequencing of sakP encoding sakacin P, the bacteriocin produced by Lactobacillus sake LTH 673. Microbiology (New York) 140:361-7.
170. Tomasz A. 1994. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller Univ. Workshop. N Engl J Med 330:1247-51.
171. Tomita H, Fujimoto S, Tanimoto K, Ike Y. 1996. Cloning and genetic organization of the bacteriocin 31 determinant encoded on the Enterococcus faecalis pheromone-responsive conjugative plasmid pYI17. J Bacteriol 178:3585-93.
172. Tossi A, Sandri L, Giangaspero A. 2000. Amphipathic, α-helical antimicrobial peptides. Biopolymers 55:4-30.
173. Turner K, Porter J, Pickup R, Edwards C. 2000. Changes in viability and macromolecular content of long-term batch cultures of Salmonella typhimurium measured by flow cytometry. J Appl Microbiol 89:90-9.
174. Ulvatne H, Vorland LH. 2001. Bactericidal kinetics of 3 lactoferricins against Staphylococcus aureus and Escherichia coli. Scand J Infect Dis 33:507-11.
175. Utsugi T, Schroit AJ, Connor J, Bucana CD, Fidler IJ. 1991. Elevated expression of phosphatidylserine in the outer membrane leaflet of human tumour cells and recognition by activated human blood monocytes. Cancer Res 51:3062-6.
176. Uyttendaele M, Debevere J. 1994. Protamine evaluation of the antimicrobial activity of protamine. Food Microb 11:417-27.
177. Vanhoye D, Bruston F, Nicolas P, Amiche M. 2003. Antimicrobial peptides from hylid and ranin frogs originated from a 150-million-year-old ancestral precursor with a conserved signal peptide but a hypermutable antimicrobial domain. Eur J Biochem 270:2068-81.
178. Van Kan EJ, Demel RA, Breukink E, van der Bent BA, Kruijff B. 2002. Clavanin permeabilizes target membranes via two distinctly different pH-dependent mechanisms. Biochemistry 41:7529-39.
179. Vogt TCB, Bechinger B. 1999. The interactions of histidine-containing amphipathic helical peptide antibiotics with lipid bilayers. The effects of charges and pH. J Biol Chem 274(41):29115-21.
180. Vouldoukis I, Shai I, Nicolas P, Mor A. 1996. Antimicrobial properties of skin-PYY. FEBS Lett 380:237-40.
181. Welling MM, Paulusma-Annema A, Balter HS, Panwels EK, Nibbering PH. 2000. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 27(3):292-301.
182. [WHO] World Health Organization. 1995. The use of essential drugs. Sixth Report of the WHO expert committee, WHO Tech. Rep. Ser. No. 850. Rome:WHO.
183. Wilcox W, Eisenberg D. 1992. Thermodynamics of melittin tetramerization determined by circular dichroism and implications for protein folding. Protein Sci 1:641-53.
184. Wu M, Maier E, Benz R, Hancock REW. 1999. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38:7235-42.
185. Yam KL, Takhistov PT, Miltz J. 2005. Intelligent packaging: concepts and applications. J Food Sci 70(1)R1-R10.
186. Yan H, Hancock REW. 2001. Synergistic interactions between mammalian antimicrobial defense peptides. Antimicrob Agents Chemother 45:1558-60.
187. Yaron S, Rydlo T, Shachar D, Mor A. 2003. Activity of dermaseptin K4-S4 against food-borne pathogens. Peptides 24(11):1815-21.
188. Yasin B, Pang M, Turner JS, Cho Y, Dinh NN, Waring AJ, Lehrer RI, Wagar EA. 2000. Evaluation of the inactivation of infectious Herpes simplex virus by host-defense peptides. Eur J Clin Microbiol Infect Dis 19:187-94.
189. Yeaman MR, Yount NY. 2003. Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55:27-55.
190. Zasloff M. 1987. Magainins, a class of antimicrobial peptides from Xenopus skin: isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc Natl Acad Sci USA 84:5449-53.
191. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-95.
192. Zasloff M, Martin B, Chen HC. 1988. Antimicrobial activity of synthetic magainin peptides and several analogues. Proc Natl Acad Sci USA 85:910-3.
193. Zhang L, Hancock REW. 2000. Peptide antibiotics. In: Hughes D, Andersson DI, editors. Antibiotic resistance and antibiotic development. Reading, Pa: Harwood Academic Publishers. 209-32.
194. Zhou YX, Cao W, Luo QP, Ma YS, Wang JZ, Wei DZ. 2005. Production and purification of a novel antibiotic peptide, adenoregulin, from a recombinant Escherichia coli. Biotechnol Lett 27(10):725-30.